jueves, 2 de noviembre de 2023

Genetics of Gastric Cancer (PDQ®)–Health Professional Version

https://www.cancer.gov/types/stomach/hp/gastric-genetics-pdq?cid=eb_govdel#top

Thyroid Cancer Screening (PDQ®)–Health Professional Version

https://www.cancer.gov/types/thyroid/hp/thryoid-screening-pdq?cid=eb_govdel#top

Prostate Cancer Screening (PDQ®)–Health Professional Version

https://www.cancer.gov/types/prostate/hp/prostate-screening-pdq?cid=eb_govdel#top

Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Screening (PDQ®)–Health Professional Version

https://www.cancer.gov/types/ovarian/hp/ovarian-screening-pdq?cid=eb_govdel#top

Childhood Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version

https://www.cancer.gov/types/soft-tissue-sarcoma/hp/child-soft-tissue-treatment-pdq?cid=eb_govdel#top

NIH researchers develop approach that could help supercharge T-cell therapies against solid tumors Early research in animal models shows potential against cervical cancer and neuroblastoma.

https://www.nih.gov/news-events/news-releases/nih-researchers-develop-approach-could-help-supercharge-t-cell-therapies-against-solid-tumors

NIH Statement on Preliminary Efficacy Results of First-in-Class Gonorrhea Antibiotic Developed Through Public-Private Partnership

https://www.niaid.nih.gov/news-events/nih-statement-preliminary-efficacy-results-first-class-gonorrhea-antibiotic-developed?utm_campaign=+58254932&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term=